MétaCan
Menu
Back to cohort
Record W2914066022 · doi:10.4212/cjhp.v52i6.1874

Heparin-Induced Thrombocytopenia

2018· article· en· W2914066022 on OpenAlexvenueaboutno aff
Theodore E. Warkentin, David Rosenbloom

Bibliographic record

VenueThe Canadian Journal of Hospital Pharmacy · 2018
Typearticle
Languageen
FieldMedicine
TopicHeparin-Induced Thrombocytopenia and Thrombosis
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineLepirudinHeparin-induced thrombocytopeniaHeparinWarfarinPlateletVenous thrombosisThrombosisArgatrobanSurgeryInternal medicineThrombin

Abstract

fetched live from OpenAlex

ABSTRACT Heparin-induced thrombocytopenia is the most common immune-mediated adverse drug reaction, occurring in 1 % to 3% of postoperative patients receiving unfractionated heparin prophylaxis for 7 to 14 days. Approximately 1 in 100 patients receiving a therapeutic dose of unfractionated heparin for a week or more will experience thrombosis related to heparin-induced thrombocytopenia. Heparin-induced thrombocytopenia is characterized by activation of coagulation and platelets. Diagnosis of the condition should take into account the timing of the thrombocytopenia (which typically occurs on day 5 to 10 after initiation of heparin), the degree of the thrombocytopenia, and the presence of new thrombosis. Use of warfarin alone to treat acute heparin-induced thrombocytopenia complicated by deep venous thrombosis sometimes results in loss of a limb because of venous limb gangrene, probably because warfarin can cause severe reduction in protein C without a simultaneous reduction in the generation of thrombin in these patients. New treatments now available in Canada to reduce thrombin generation in heparin-induced thrombocytopenia (such as danaparoid and lepirudin) are useful in managing the thrombotic consequences of heparin-induced thrombocytopenia. RESUME La thrombocytopenie d'origine heparinique represente la reaction indesirable d'origine immunologique la plus courante. En effet, elle survient chez 1 % a 3 % des patients qui recoivent un traitement prophylactique post-operatoire a l'heparine non fractionnee durant 7 a 14 jours. Environ 1 patient sur 100 qui recoivent une dose therapeutique d'heparine non fractionnee pendant une semaine ou plus souffrira de thrombose associee a une thrombocytopenie d'origine heparinique. La thrombocytopenie d'origine heparinique est caracterisee par l'activation de la coagulation et des plaquettes. Le diagnostic de cette affection devrait tenir compte du moment auquel survient la thrombocytopenie (cette derniere survenant habituellement entre le cinquieme et le dixieme jour apres le debut de l'heparinotherapie), du degre de la thrombocytopenie et de la presence de nouveaux thrombi. Le recours a la warfarine seule pour traiter une thrombocytopenie aigue d'origine heparinique compliquee par une thrombose veineuse profonde peut entrainer quelques fois la perte d'un membre a cause d'une gangrene veineuse du membre, probablement parce que la warfarine cause une diminution prononcee du taux de proteine C sans reduction simultanee du taux de thrombine chez ces patients. Les nouveaux traitements maintenant offerts au Canada pour reduire la production de thrombine dans les cas de thrombocytopenie d'origine heparinique (comme le danaparoicle et la lepirudine) sont utiles dans le traitement des consequences thrombotiques de la thrombocytopenie d'origine heparinique.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.014
Threshold uncertainty score0.047

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0140.004

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.052
GPT teacher head0.329
Teacher spread0.278 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2018
Admission routes2
Has abstractyes

Explore more

Same venueThe Canadian Journal of Hospital PharmacySame topicHeparin-Induced Thrombocytopenia and ThrombosisFrench-language works237,207